Navidea Biopharmaceuticals, Inc.
NAVB · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,177 | -$11,731 | -$10,722 | -$10,948 |
| Dep. & Amort. | $96 | $77 | $70 | $145 |
| Deferred Tax | $0 | -$267 | $6 | $60 |
| Stock-Based Comp. | $301 | $471 | $231 | $232 |
| Change in WC | $5,118 | $947 | $1,840 | $1,122 |
| Other Non-Cash | $675 | $285 | $402 | $34 |
| Operating Cash Flow | -$8,987 | -$10,218 | -$8,174 | -$9,355 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$63 | -$329 | -$414 | -$57 |
| Net Acquisitions | $0 | $0 | $1 | $27 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $800 |
| Other Inv. Act. | -$327 | $0 | $0 | $0 |
| Investing Cash Flow | -$390 | -$329 | -$413 | $770 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,982 | -$492 | -$3 | -$359 |
| Stock Issued | $0 | $4 | $4,443 | $7,087 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,160 | $12,595 | $5,770 | -$572 |
| Financing Cash Flow | $7,142 | $12,108 | $10,210 | $6,156 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,235 | $1,560 | $1,623 | -$2,429 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,231 | $2,670 | $1,047 | $3,476 |
| End Cash | $1,996 | $4,231 | $2,670 | $1,047 |
| Free Cash Flow | -$9,377 | -$10,548 | -$8,588 | -$9,411 |